Eqalix, Inc. is an emerging regenerative medicine development company pioneering new technologies intended to revolutionize patient, family and consumer needs in multiple commercial and therapeutic applications. Regenerative medicine holds great promise and hope to change the future of healing both diseased and traumatized tissue and organs. We are steadfast to be the leader in the forefront of regenerative medicine, delivering real-world technologies to impact the lives of those in need.*
We are committed to being a fiscally responsible organization to ALL of our stakeholders. In our dedication to adhere to this stringent objective:
- We are developing our technologies in a staged approach
- We are focusing on early revenue generated from the consumer market to further commercialization of our other technologies
- We will maintain our status as a virtual company
- We operate our R & D at Temple University via our Sponsored Research Agreement
- We work closely with our co-development partners
- We utilize the industry expertise of our Scientific Advisory Board
- Seek government grants and sponsorships
“Regenerative Medicine (RM) is a revolutionary field focused on development and application of cell-based therapies & related technologies to enhance the natural healing process, and/or replace or regenerate organs and tissues. RM is focused on addressing the underlying clinical problem, and doing it cost effectively – not just providing palliative care.” Alliance for Regenerative Medicine
2013 Regenerative Medicine State of the Industry Briefing by Geoff MacKay, Chairman ARM: The Alliance for Regenerative Medicine’s third annual State of the Industry Briefing – which occurred on January 8, 2013 – provided an overview of recent advances in the clinic in major disease areas as well as the outlook for 2013 for the regenerative medicine and cell therapy sectors.
*Under U.S. law, a new drug or medical device cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use.